Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

Ling-Yu Zhu,Jun-Bo Yuan,Li Zhang,Chun-Xiao He,Xiao Lin,Bin Xu,Guang-Hui Jin

DOI: https://doi.org/10.1158/0008-5472.22432688

2023-01-01

Abstract:Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

What problem does this paper attempt to address?

Loss of MLL induces epigenetic dysregulation of Rasgrf1 to attenuate Kras-driven lung tumorigenesis

Ling-Yu Zhu,Jun-Bo Yuan,Li Zhang,Chun-Xiao He,Xiao Lin,Bin Xu,Guang-Hui Jin

DOI: https://doi.org/10.1158/0008-5472.can-22-1475

IF: 11.2

2022-09-14

Cancer Research

Abstract:Menin is necessary for the formation of the menin/MLL complex and is recruited directly to chromatin. Menin is an important tumor suppressor in several cancer types, including lung cancer. Here, we investigated the role of MLL in menin-regulated lung tumorigenesis. Ablation of MLL suppressed KrasG12D-induced lung tumorigenesis in a genetically-engineered mouse model. MLL deficiency decreased histone H3 lysine 4 trimethylation (H3K4me3) and subsequently suppressed expression of the Ras protein-specific guanine nucleotide-releasing factor 1 (Rasgrf1) gene. Rasgrf1 was essential for the GTP-bound active state of Kras and the activation of Kras downstream pathways as well as their cancer-promoting activities. MI-3, a small molecule inhibitor targeting MLL, specifically inhibited the growth of Kras-mutated lung cancer cells in vitro and in vivo with minimal effect on wild-type Kras lung cancer growth. Together, these results demonstrate a novel tumor promoter function of MLL in mutant Kras-induced lung tumorigenesis and further indicate that specific blockade of the MLL-Rasgrf1 pathway may be a potential therapeutic strategy for the treatment of tumors containing Kras mutations.

oncology
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figures 1-4 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Kentaro Iwanaga,Yanan Yang,Maria Gabriela Raso,Lijiang Ma,Amy E. Hanna,Nishan Thilaganathan,Seyed Moghaddam,Christopher M. Evans,Huaiguang Li,Wei-Wen Cai,Mitsuo Sato,John D. Minna,Hong Wu,Chad J. Creighton,Francesco J. Demayo,Ignacio I. Wistuba,Jonathan M. Kurie

DOI: https://doi.org/10.1158/0008-5472.22373654.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer
Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Hongbin Ji,Zhenxiong Wang,Samanthi A. Perera,Danan Li,Mei‐Chih Liang,Sara Zaghlul,Kate McNamara,Liang Chen,Aaron P. Mitchell,Yi Sun,Ruqayyah Al-Hashem,Lucian R. Chirieac,Robert F. Padera,Roderick T. Bronson,Roman K. Thomas,Levi A. Garraway,Pasi A. Jänne,Bruce E. Johnson,Lynda Chin,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22367994.v1

2023-01-01

Abstract:Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Supplementary Figure 4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Hongbin Ji,Zhenxiong Wang,Samanthi A. Perera,Danan Li,Mei-Chih Liang,Sara Zaghlul,Kate McNamara,Liang Chen,Mitchell Albert,Yanping Sun,Ruqayyah Al-Hashem,Lucian R. Chirieac,Robert Padera,Roderick T. Bronson,Roman K. Thomas,Levi A. Garraway,Pasi A. Jänne,Bruce E. Johnson,Lynda Chin,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22367985.v1

2023-01-01

Abstract:Supplementary Figure 4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Supplementary Figure 2 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Hongbin Ji,Zhenxiong Wang,Samanthi A. Perera,Danan Li,Mei-Chih Liang,Sara Zaghlul,Kate McNamara,Liang Chen,Mitchell Albert,Yanping Sun,Ruqayyah Al-Hashem,Lucian R. Chirieac,Robert Padera,Roderick T. Bronson,Roman K. Thomas,Levi A. Garraway,Pasi A. Jänne,Bruce E. Johnson,Lynda Chin,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22367991

2023-01-01

Abstract:Supplementary Figure 2 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Hongbin Ji,Zhenxiong Wang,Samanthi A. Perera,Danan Li,Mei-Chih Liang,Sara Zaghlul,Kate McNamara,Liang Chen,Mitchell Albert,Yanping Sun,Ruqayyah Al-Hashem,Lucian R. Chirieac,Robert Padera,Roderick T. Bronson,Roman K. Thomas,Levi A. Garraway,Pasi A. Jänne,Bruce E. Johnson,Lynda Chin,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22367988.v1

2023-01-01

Abstract:Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Supplementary Figures 1-2 from Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor

Yulong Chen,Jiong Deng,Junya Fujimoto,Humam Kadara,Taoyan Men,Dafna Lotan,Reuben Lotan

DOI: https://doi.org/10.1158/0008-5472.22386399.v1

2023-01-01

Abstract:Supplementary Figures 1-2 from Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor
Supplementary Figure from TGF-β-Induced FLRT3 Attenuation is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer

Mengdi Yang,Dan Li,Zhiyuan Jiang,Changcan Li,Suyuan Ji,Jing Sun,Yujie Chang,Shunyi Ruan,Zhiyu Wang,Rui Liang,Xueyu Dai,Bin Li,Hui Zhao

DOI: https://doi.org/10.1158/1541-7786.22527761.v1

2023-01-01

Abstract:Supplementary Figure from TGF-β-Induced FLRT3 Attenuation Is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer
Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Yifan Wang,Nan Li,Jinyu Wen,Weiye Deng,Rui Ye,Xu Cai,Yawei Qiao,Amrish Sharma,Ming Zhang,Mien‐Chie Hung,Steven H. Lin

DOI: https://doi.org/10.1158/1078-0432.22469730.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409370.v1

2023-01-01

Abstract:Legend for Supplementary Figures S1-S8
Supplementary Figure S2 from Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Shaoxing Guan,Xi Chen,Yuru Wei,Fei Wang,Wen Xie,Youhao Chen,Heng Liang,Xia Zhu,Yunpeng Yang,Wenfeng Fang,Yan Huang,Hongyun Zhao,Xiaoxu Zhang,Shu Liu,Wei Zhuang,Min Huang,Xueding Wang,Li Zhang

DOI: https://doi.org/10.1158/1078-0432.25515874.v1

2024-01-01

Abstract:Figure S2. High USP36 expression level promoted migration and proliferation of EGFRmutant NSCLC
Supplementary Figure S2 from Mir-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409364.v1

2023-01-01

Abstract:Mutation Background of Non-Small Cell Lung Cancer Lines.
Supplementary Table 3 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Kentaro Iwanaga,Yanan Yang,Maria Gabriela Raso,Lijiang Ma,Amy E. Hanna,Nishan Thilaganathan,Seyed Moghaddam,Christopher M. Evans,Huaiguang Li,Wei-Wen Cai,Mitsuo Sato,John D. Minna,Hong Wu,Chad J. Creighton,Francesco J. Demayo,Ignacio I. Wistuba,Jonathan M. Kurie

DOI: https://doi.org/10.1158/0008-5472.22373651

2023-01-01

Abstract:Supplementary Table 3 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer
Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Hongbin Ji,Zhenxiong Wang,Samanthi A. Perera,Danan Li,Mei-Chih Liang,Sara Zaghlul,Kate McNamara,Liang Chen,Mitchell Albert,Yanping Sun,Ruqayyah Al-Hashem,Lucian R. Chirieac,Robert Padera,Roderick T. Bronson,Roman K. Thomas,Levi A. Garraway,Pasi A. Jänne,Bruce E. Johnson,Lynda Chin,Kwok-Kin Wong

DOI: https://doi.org/10.1158/0008-5472.22367982.v1

2023-01-01

Abstract:Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

Jing Yang,Changchun Hou,Huashan Wang,Hanh Chi Do-Umehara,Huali Dong,Vinothini Arunagiri,Fangjia Tong,Michelle Van Scoyk,Minsu Cho,Xinyi Liu,Xiaodong Ge,Xiaowei Wang,Jing Liu,Edith A. Perez,Robert A. Winn,Karen M. Ridge,Navdeep S. Chandel

DOI: https://doi.org/10.1016/j.canlet.2022.216025

IF: 9.756

2022-12-19

Cancer Letters

Abstract:Targeting KRAS-mutated non-small-cell lung cancer (NSCLC) remains clinically challenging. Here we show that loss of function of Miz1 inhibits lung tumorigenesis in a mouse model of oncogenic KRAS-driven lung cancer. In vitro , knockout or silencing of Miz1 decreases cell proliferation, clonogenicity, migration, invasion, or anchorage-independent growth in mutant (MT) KRAS murine or human NSCLC cells but has unremarkable impact on non-tumorigenic cells or wild-type (WT) KRAS human NSCLC cells. RNA-sequencing reveals Protocadherin-10 (Pcdh10) as the top upregulated gene by Miz1 knockout in MT KRAS murine lung tumor cells. Chromatin immunoprecipitation shows Miz1 binding on the Pcdh10 promoter in MT KRAS lung tumor cells but not non-tumorigenic cells. Importantly, silencing of Pcdh10 rescues cell proliferation and clonogenicity in Miz1 knockout/knockdown MT KRAS murine or human tumor cells, and rescues allograft tumor growth of Miz1 knockout tumor cells in vivo . Miz1 is upregulated in MT KRAS lung tumor tissues compared with adjacent non-involved tissues in mice. Consistent with this, Miz1 is upregulated while Pcdh10 is downregulated in human lung adenocarcinomas (LUAD) compared with normal tissues, and high Miz1 levels or low Pcdh10 levels are associated with poor survival in lung cancer patients. Furthermore, the Miz1 signature is associated with worse survival in MT but not WT KRAS LUAD, and Pcdh10 is downregulated in MT compared to WT KRAS LUAD. Taken together, our studies implicate the Miz1/Pcdh10 axis in oncogenic KRAS-driven lung tumorigenesis.

oncology
Supplementary Tables 1-2 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Kentaro Iwanaga,Yanan Yang,Maria Gabriela Raso,Lijiang Ma,Amy E. Hanna,Nishan Thilaganathan,Seyed Moghaddam,Christopher M. Evans,Huaiguang Li,Wei-Wen Cai,Mitsuo Sato,John D. Minna,Hong Wu,Chad J. Creighton,Francesco J. Demayo,Ignacio I. Wistuba,Jonathan M. Kurie

DOI: https://doi.org/10.1158/0008-5472.22373648.v1

2023-01-01

Abstract:Supplementary Tables 1-2 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer
Supplementary Figure S1 from Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Shaoxing Guan,Xi Chen,Yuru Wei,Fei Wang,Wen Xie,Youhao Chen,Heng Liang,Xia Zhu,Yunpeng Yang,Wenfeng Fang,Yan Huang,Hongyun Zhao,Xiaoxu Zhang,Shu Liu,Wei Zhuang,Min Huang,Xueding Wang,Li Zhang

DOI: https://doi.org/10.1158/1078-0432.25515877

2024-01-01

Abstract:Figure S1. USP36 expression level predicted response of EGFR-TKIs in EGFR-mutant NSCLC.

Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

Loss of MLL induces epigenetic dysregulation of Rasgrf1 to attenuate Kras-driven lung tumorigenesis

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figures 1-4 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 2 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figures 1-2 from Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor

Supplementary Figure from TGF-β-Induced FLRT3 Attenuation is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Figure S2 from Germline <i>USP36</i> Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Supplementary Figure S2 from Mir-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Table 3 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

Supplementary Tables 1-2 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure S1 from Germline <i>USP36</i> Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

Loss of MLL induces epigenetic dysregulation of Rasgrf1 to attenuate Kras-driven lung tumorigenesis

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figures 1-4 from &lt;i&gt;Pten&lt;/i&gt; Inactivation Accelerates Oncogenic &lt;i&gt;K-ras&lt;/i&gt;–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 2 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Supplementary Figures 1-2 from Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor

Supplementary Figure from TGF-β-Induced FLRT3 Attenuation is Essential for Cancer-Associated Fibroblast–Mediated Epithelial–Mesenchymal Transition in Colorectal Cancer

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Figure S2 from Germline &lt;i&gt;USP36&lt;/i&gt; Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Supplementary Figure S2 from Mir-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Table 3 from &lt;i&gt;Pten&lt;/i&gt; Inactivation Accelerates Oncogenic &lt;i&gt;K-ras&lt;/i&gt;–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

Supplementary Tables 1-2 from &lt;i&gt;Pten&lt;/i&gt; Inactivation Accelerates Oncogenic &lt;i&gt;K-ras&lt;/i&gt;–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure S1 from Germline <i>USP36</i> Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Supplementary Figures 1-4 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Figure S2 from Germline <i>USP36</i> Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

Supplementary Table 3 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Supplementary Tables 1-2 from <i>Pten</i> Inactivation Accelerates Oncogenic <i>K-ras</i>–Initiated Tumorigenesis in a Mouse Model of Lung Cancer